I n February 2014, Medicare announced the decision to cover cardiac rehabilitation for patients with chronic heart failure (HF) with reduced ejection fraction. Despite the known benefits of cardiac rehabilitation for patients with HF and other cardiovascular diseases, it has been shown to be an underutilized therapy. 1 Among patients who do participate, adherence may be less than recommended. 2 Even in a clinical trial setting, many patients do not fully adhere to recommended exercise programs. 3 It is important to understand the reasons for poor exercise adherence and how low adherence affects clinical outcomes. In addition to physical limitations, psychosocial factors may also influence adherence to exercise. To date, there are limited data characterizing the relationship of psychosocial factors to exercise adherence in HF patients. Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) was the largest clinical trial to assess the safety and efficacy of aerobic exercise training in patients with HF with reduced ejection fraction. 3 Exercise training was associated with reduced incidence of all-cause mortality or all-cause hospitalization and cardiovascular mortality or HF hospitalization.
to assess perceived social support. We also explored a novel tool to assess perceived barriers to participation in an exercise program. We hypothesized that lower levels of social support and more perceived barriers to exercise would be associated with worse adherence to an exercise training program and worse outcomes.
Methods

Trial Overview
The design and primary results of the HF-ACTION study have been published previously. 3, 4 Briefly, this was a multicenter, randomized controlled trial designed to evaluate the efficacy and safety of exercise training in patients with stable chronic HF (New York Heart Association Class II-IV) with reduced ejection fraction (left ventricular ejection fraction ≤35%). Patients were randomized to usual care or usual care plus aerobic exercise training. Exercise training consisted of supervised exercise 3 times per week for 36 sessions over 3 months, with increasing duration and intensity over time, with a gradual transition to a home exercise program for an additional 2 years. The exercise training goal was 90 minutes per week for the first 3 months, then 120 minutes per week thereafter. The protocol was approved by the institutional review board or ethics committee at each institution and the coordinating center. All patients provided written informed consent.
The primary end point was all-cause mortality or all-cause hospitalization, and the secondary end points were all-cause mortality, cardiovascular mortality or cardiovascular hospitalization, and cardiovascular mortality or HF hospitalization. An independent committee blinded to treatment assignment adjudicated clinical events.
Assessments
Patients enrolled in HF-ACTION were asked to assess sources of social support and anticipate potential barriers to participation in the study. The Perceived Social Support Scale is a validated tool to asses feelings of social support (eg, My family really tries to help me, I can talk about my problems with my friends) in which patients rate 12 statements on a 7-point scale (ie, very strongly disagree [1] , strongly disagree [2] , mildly disagree [3] , neutral [4] , mildly agree [5] , strongly agree [6] , very strongly agree [7] ). 5 Perceived social support scores (PSSS) range from 12 to 84, with higher scores indicating a higher level of perceived social support. The Barrier Scale is a novel scale developed for this study which asked patients to evaluate the extent to which 10 potential barriers (eg, finances, child care, weather) might interfere with their participation in an exercise program on a 3-point scale (ie, not at all [1] , somewhat [2] , a lot [3] ). Barriers to exercise scores (BTES) range from 10 to 30, with higher scores indicating more barriers to exercise. Surveys were completed at baseline and 12 months (see Appendix in the Data Supplement for complete Perceived Social Support Scale and Barriers to Exercise Scale). Patients also completed the Beck Depression Inventory II (BDI-II) and the Kansas City Cardiomyopathy Questionnaire (KCCQ) at baseline, every 3 months for the first year, and yearly thereafter.
Exercise adherence was assessed in patients randomized to exercise therapy and was measured by minutes per week of exercise, described as poor adherence (<90 minutes/week), partial adherence (≥90 minutes/week for 3 months, then <120 minutes/week thereafter), or full adherence (≥90 minutes/week for 3 months, then ≥120 minutes/week). Cardiopulmonary exercise testing was completed at baseline, 3 months, 12 months, and 24 months. Cardiopulmonary exercise testing was performed using a modified Naughton treadmill protocol or a leg ergometer, and exercise continued until sign-or symptomlimited maximal exertion was reached. Peak oxygen uptake (VO 2 ) was defined as the VO 2 at peak exercise, either within the last 90 seconds of exercise or the first 30 seconds of recovery, whichever was higher. Cardiopulmonary exercise data were analyzed at a core laboratory.
Statistical Analyses
Baseline characteristics were reported by level of exercise adherence throughout the duration of the study among patients in the exercise arm of the study, alive at 12 months, and with adherence measured at both 3 and 12 months. Continuous variables were reported as medians with 25th and 75th percentiles and compared using the Kruskal-Wallis test. Categorical variables were reported as frequencies and percentages and compared using Pearson Chi-square or Fisher's exact tests.
We used unadjusted Spearman correlation to assess whether baseline PSSS was associated with adherence to exercise at 3 months or 12 months. Similar methods were used to assess whether baseline PSSS was associated with baseline depression, as measured by the BDI-II, or baseline or change in quality of life, as measured by the KCCQ. We also used Spearman correlation to assess whether baseline PSSS was associated with change in exercise capacity from baseline to 12 months, as measured by peak VO 2 . To visualize the data, we provide descriptive statistics by quintile of PSSS. Kaplan-Meier methods were used to compare outcomes by quintiles of PSSS; logrank test P values compare survival across quintiles. We used paired t test to compare scores at baseline and 12 months.
Cox proportional hazards models assessed the association between baseline PSSS and clinical outcomes. PSSS was evaluated as a continuous variable; in additional analyses, we also evaluated PSSS dichotomized as above the median or at or below the median in Cox models. Linearity of the relationship between continuous PSSS and the log hazard rate was assessed by a likelihood ratio test comparing the linear fit to the fit of a restricted cubic spline transformation. The proportional hazards assumption was assessed by plotting Schoenfeld residuals against functions of time and calculating the correlation of these. For both assumptions, no violations were detected. The unadjusted model included baseline PSSS, whereas the adjusted model included baseline score and adjustment variables that were previously used in other post hoc HF-ACTION analyses. [6] [7] [8] [9] [10] We assessed whether belonging to certain subgroups modified the association between PSSS and outcomes using interactions. When significant, the association between PSSS and outcome was reported by subgroup. The analysis was repeated for BTES.
Cox proportional hazards models were also used to assess the association between exercise adherence and clinical outcomes after 1 year. We used weighting methods to account for missing exercise adherence data. Weights were calculated as the inverse of a patient's estimated probability to have nonmissing end point data. 11 A sensitivity analysis was done without the inverse weighting method, with similar results.
Two-tailed P values <0.05 were considered statistically significant. SAS version 9.2 or higher (SAS Institute Inc., Cary, NC) was used for all analyses.
Results
Of the 2331 patients enrolled in HF-ACTION, 2279 (97.8%) patients completed baseline surveys to assess for feelings of social support and perceived barriers to exercise with 1090 randomized to exercise training ( Figure 1 ). For patients randomized to exercise training with completed surveys and adherence data, baseline PSSS weakly correlated with exercise time (minutes/week) at 3 and 12 months (r=0.09 and r=0.13, respectively) as did baseline BTES (r=−0.11 and r=−0.12, respectively, all P<0.01; Figure 2 ). For the highest quintile PSSS compared with the lowest quintile, median exercise time at 3 months was 79 minutes/week versus 71 minutes/week and at 12 months was 118 minutes/week versus 92 minutes/week, respectively. For the lowest quintile BTES compared with the highest quintile, median exercise time at 3 months was 89 minutes/week versus 70 minutes/week and at 12 months was 169 minutes/week versus 86 minutes/week, respectively. Table 1 describes the baseline characteristics of the participants in the exercise training group with completed baseline surveys, grouped by adherence to exercise. Although 1090 patients in the exercise training group had completed baseline surveys, only 935 had complete exercise adherence data and were included in Table 1 . Overall, more patients were poorly adherent than fully adherent. Patients with poor adherence were more likely to be younger, female, and black, with higher body mass index. At baseline, patients with poor adherence were more likely to have New York Heart Association Class III-IV symptoms, but the frequency of prior HF hospitalization was similar between groups. Patients with poor adherence also had significantly worse baseline exercise capacity as measured by peak VO 2 and 6-minute walk test distance. Patients with poor adherence had lower quality of life as measured by the KCCQ and higher levels of depression as measured by the BDI-II score compared with patients with full adherence and partial adherence. Furthermore, poorly adherent patients were less likely to be married or living with a partner than fully adherent patients.
For all patients with baseline and 12-month PSSS and BTES data, regardless of randomization group, PSSS and BTES were not significantly different between baseline and 1 year, with a median PSSS of 72 (interquartile range: 62, 80) at baseline and 72 (interquartile range: 63, 81) at follow-up and a median BTES of 12 (interquartile range: 11, 14) at baseline and 12 (interquartile range: 10, 14) at follow-up. Figure 3 shows the distribution of scores at baseline and follow-up.
For all patients, baseline PSSS correlated with baseline measures of depression and quality of life ( Table 2) . As PSSS increased, KCCQ scores also increased (r=0.29, P<0.0001) and BDI-II score decreased (r=−0.36, P<0.0001). Baseline BTES also correlated modestly with baseline BDI-II score (r=0.29, P<0.0001) and KCCQ scores (r=−0.22, P<0.0001). Baseline PSSS and BTES were not significantly correlated with change in KCCQ from baseline to 12 months.
For all patients, regardless of whether they were randomized to exercise training or usual care, neither baseline PSSS nor baseline BTES was significantly correlated with change in peak VO 2 from baseline to 12 months (r=−0.005, P=0.86 and r=0.04, P=0.10, respectively).
There was no association between PSSS and the primary outcome of all-cause death or hospitalization (P=0.98). There was, however, a trend toward an association between BTES and all-cause death or hospitalization events, with higher quintiles associated with more events than lower quintiles (P=0.05). The unadjusted Kaplan-Meier event curves for the primary end-point of all-cause death or hospitalization based on baseline PSSS and BTES are included in Appendix in the Data Supplement.
In unadjusted and adjusted Cox regression models, there was no association between baseline PSSS and all-cause death or hospitalization (Table 3 ). For BTES, however, in Cox regression models, when BTES was divided at the median, there was a trend toward a significant association between baseline BTES and all-cause death or hospitalization ( adjusted (HR 0.99, 95% CI 0.88, 1.11, P=0.83) analyses. The secondary outcome of cardiovascular death or HF hospitalization was not associated with baseline PSSS or baseline BTES in either unadjusted or adjusted analyses (Table 3) . We tested the interaction between scores and randomization group or demographic subgroups for long-term outcomes. There were no significant interactions between baseline PSSS and randomization group, age, sex, race, cause of HF, New York Heart Association Class, or depression score for all-cause mortality or hospitalization (Appendix in the Data Supplement). There were also no significant interactions with baseline PSSS and subgroups for cardiovascular death or HF hospitalization. There was, however, a signal for interaction between baseline BTES and baseline BDI-II score (P=0.056) and a significant interaction between baseline BTES and randomization arm for cardiovascular death or HF hospitalization (P=0.035; Appendix in the Data Supplement and Table 1 ). The latter interaction was because of a borderline association between increasing BTES and increased cardiovascular death or HF hospitalization for the exercise group (HR 1.25, 95% CI 0.99, 1.59) that was not seen in the usual care group (HR 0.83, 95% CI 0.66, 1.06). No other interactions were found for baseline BTES and cardiovascular death or HF hospitalization by defined subgroups.
There was no association between exercise adherence and the primary outcome of all-cause death or hospitalization (Table 4 ). Compared with full adherence, poor exercise adherence was associated with a higher risk of cardiovascular death or HF hospitalization (HR 1.47, 95% CI 1.02, 2.11, P=0.04). This association remained after controlling for adjustment variables (HR 1.83, 95% CI 1.15, 2.92, P=0.01).
Discussion
Exercise programs, although proven to be safe and effective for HF patients, are often poorly followed. 1, 2 This study examined HF patient characteristics associated with poor exercise adherence and the influence of perceived social support on exercise adherence and long-term outcomes. This study also explored the association of barriers to exercise with exercise adherence and outcomes and the association of exercise adherence with outcomes. Social support and barriers to exercise correlated with exercise adherence, consistent with our hypothesis; however, they were not independently associated with clinical outcomes, though barriers to exercise impacted the effect of exercise training on cardiovascular death or HF hospitalization.
Table 2. Correlation Between Baseline Scores and Baseline Depression and Baseline and Change in Quality of Life
Both physical and psychosocial factors were associated with exercise adherence. Patients with poor exercise adherence throughout the study period had worse functional class and exercise capacity at baseline, as measured by peak VO 2 and 6-minute walk distance. Patients with higher perceived social support exercised more than those with lower perceived social support. Similarly, patients with fewer barriers to exercise exercised more than those with more barriers to exercise.
The perceived social support scale and barriers to exercise scale are 2 tools that can be used to assess patients' psychosocial health status, which may impact adherence to treatment recommendations. Prior studies have shown that the KCCQ score correlates with the PSSS, and our study also shows a weak correlation between these scores. 12 KCCQ was also weakly correlated with BTES. Importantly, exercise training has been shown to result in improvement in KCCQ score, and KCCQ score has been shown to be associated with outcomes, including functional measures and clinical end points. [13] [14] [15] [16] [17] However, in our study, neither the baseline PSSS nor BTES correlated with change in KCCQ from baseline to 12 months. Furthermore, both the PSSS and BTES correlate modestly with measures of depression. However, neither PSSS nor BTES changed over time. Thus, although exercise training has been shown to alleviate symptoms of depression, it does not seem to change the perception of social support or barriers to exercise. 6, [18] [19] [20] [21] The results of this study, and other studies of psychosocial interventions in HF patients, highlight how difficult it is to affect meaningful psychosocial changes in these patients. 22 The HF-ACTION study showed that exercise training for patients with chronic HF improved peak VO 2 at 3 and 12 months. 3 Subsequent analyses demonstrated that the increase in peak VO 2 at 3 months was associated with a lower risk of allcause mortality or all-cause hospitalization and cardiovascular mortality or HF hospitalization. 23 Our study examined VO 2 at 12 months and found that baseline PSSS and BTES were not associated with a change in peak VO 2 from baseline to 12 months.
Furthermore, the HF-ACTION study showed that exercise training reduced all-cause mortality and hospitalizations in chronic HF patients. 3 However, even in the clinical trial setting, only one-third of the patients randomized to exercise training were fully adherent to the recommended exercise program. In clinical practice, the rates of adherence with recommended exercise are likely to be even lower, potentially limiting the effectiveness of exercise training for improving clinical outcomes. Although HF patients may have physical and cardiopulmonary limitations to exercise, it is important to recognize that psychosocial factors may also limit a patient's ability or perceived ability to exercise. Regardless of treatment arm, we sought to determine whether psychosocial factors influenced outcomes in HF patients. We found that perceived social support was not associated with all-cause death or hospitalization or with cardiovascular death or HF hospitalization, consistent with a prior study that did not show an association between PSSS and cardiovascular mortality. 24 However, prior studies have shown an association between PSSS and treatment adherence in various conditions, including fluid restriction in renal failure, immunosuppression in organ transplantation, and medication compliance in HF. [25] [26] [27] This study adds to that literature showing an association between PSSS and exercise adherence in HF. Although a direct link between perceived social support and outcomes was not observed in this study, higher levels of social support tended to be associated with higher levels of exercise adherence. In examining the novel BTES, we found a trend toward an association between higher baseline barrier score and increased all-cause death or hospitalization, though this association did not persist after multivariable adjustment. Thus, barriers to exercise training may capture psychosocial factors associated with worse outcomes, but the BTES may not offer independent prognostic information above and beyond recognized prognostic variables. There was a significant interaction between baseline BTES and randomization arm with respect to cardiovascular death or HF hospitalization. This was because of a borderline association in the exercise training group between higher baseline BTES and increased cardiovascular death or HF hospitalizations, which was not seen in the usual care group. This suggests that exercise training may be more beneficial for those with lower BTES, which may be related to exercise adherence because those with fewer barriers to exercise had higher levels of exercise adherence. Continued study is warranted to further explore and validate the BTES. Moreover, because neither PSSS nor BTES changed during the course of this study, future studies should assess whether exercise programs that incorporate personalized strategies to reduce patient-perceived barriers to exercise training may translate into improved psychosocial factors, exercise adherence, and clinical outcomes.
We showed that exercise adherence, as measured as minutes of exercise per week, is independently associated with cardiovascular death or HF hospitalization. These findings add to results from a prior HF-ACTION analysis, which included exercise intensity along with exercise time, and showed that moderate exercise was associated with decreased risk of cardiovascular death or HF hospitalization. 28 Because exercise volume has been associated with outcomes, the assessment of and intervention on support structures for HF patients may offer a way to facilitate improved health behaviors and potentially improve outcomes. 28 These hypotheses warrant future prospective study.
Although both physical limitations and lack of psychosocial support may limit a patient's ability to adhere to an exercise training program, it is important to note that even low levels of exercise have been shown to be beneficial compared with no exercise at all. 29, 30 As cardiac rehabilitation referrals for HF patients increase, clinicians must recognize the factors that limit a patient's ability to participate and thus realize the full benefits of this therapy. These results highlight the need to assess for social support and barriers to exercise and recognize when these social factors may limit the patient's participation in an exercise training program. By identifying patients at high risk for exercise nonadherence, providers can address these limitations in an effort to increase adherence.
Our study has several limitations. First, there is a selection bias inherent in clinical trials. HF-ACTION only enrolled patients who were deemed able to participate in an exercise training program; therefore, patients with poor social support or seemingly insurmountable barriers to exercise could not be enrolled, limiting the more extreme examples of inability to exercise because of psychosocial factors. Furthermore, men and younger patients were overrepresented compared with the general population with HF, potentially limiting generalizability. Second, although the PSSS is a validated tool to measure perceived social support, the BTES is a new assessment tool developed for the HF-ACTION protocol and has not been used or validated in other studies. Third, we did not adjust for multiplicity of statistical testing; thus, these data should be viewed as exploratory.
In conclusion, psychosocial limitations adversely affect adherence to an exercise program in patients with HF, but social support and barriers to exercise were not independently associated with clinical outcomes in HF-ACTION. However, a higher BTES reduced the exercise training effect on the outcome of cardiovascular death or HF hospitalization. Because exercise training has been shown to improve outcomes in this population, increasing exercise adherence is an important goal in the care of patients with HF. Assessment of patient-reported social support and perceived barriers may facilitate individualized approaches to implement and sustain exercise training therapy in clinical practice.
